Construction method of chondroitin-4-O-sulfotransferase mutant
By performing specific site mutations and designing fusion tags for C4ST, the problems of insufficient solubility and catalytic activity of C4ST were solved, and the industrial production of chondroitin sulfate A with high efficiency was realized.
Patent Information
- Application Number
- CN202610593984.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-30
- Publication Date
- 2026-07-24
AI Technical Summary
Wild-type C4ST has low soluble expression levels and insufficient intrinsic specific enzyme activity, making it difficult to meet the requirements for industrial production of chondroitin sulfate A.
By making specific site mutations on the wild-type C4ST amino acid sequence, combining the fusion solubilizing tag SUMO and the linker peptide AE, a C4ST mutant was constructed and expressed in Escherichia coli or Pichia pastoris. The reaction conditions were optimized to improve enzyme activity.
The soluble expression level and catalytic activity of the C4ST mutant were significantly improved. The enzyme activity of the single-point mutant in Pichia pastoris shake flask reached 2840 U/L, and the enzyme activity of the three-point combination mutant in a 5 L fermenter reached 76328 U/L. The degree of sulfonation can reach 97.0%, which meets the requirements of industrial production.